Rcsat Pharmaceuticals Private Limited
About Rcsat Pharmaceuticals Private Limited
Data last updated:
Rcsat Pharmaceuticals Private Limited is a private limited company based in Meerut, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 November 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74999UP2016PTC087624. Its GSTIN is 09AAICR0084N1ZW (Uttar Pradesh).
The company has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors including Chandresh and Aparna Rajnath Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No. 148 Akshardham Colony Roorkee Road, Meerut, Uttar Pradesh, India – 250110.
As per the financials filed for FY 2025, the company reported a revenue of ₹66.71 Lakh, a decline of 38% compared to the previous year. For the same year it recorded a net profit of ₹1.68 Lakh (net margin 2.5%) and EBITDA of ₹20.64 Lakh (EBITDA margin 30.9%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years and 17% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Rcsat Pharmaceuticals Private Limited's registered office is in Meerut, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH No. 148 Akshardham Colony Roorkee Road, Meerut, Uttar Pradesh, India – 250110
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Rcsat Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rcsat Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rcsat Pharmaceuticals Private Limited, buy the company report.
Financials of Rcsat Pharmaceuticals Private Limited
FY 2025 filings availableRcsat Pharmaceuticals Private Limited reported revenue of ₹66.71 Lakh (down 38% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 17% over five years, including a 38% fall in the latest year. EBITDA fell 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20.64 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.68 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 30.9% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rcsat Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rcsat Pharmaceuticals Private Limited
Rcsat Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandresh | Director | 09 Nov 2016 | 9 Years 11 Months | Current |
| Aparna Rajnath Singh | Director | 31 May 2018 | 8 Years 4 Months | Current |
| Ram Chander | Director | 09 Nov 2016 | 9 Years 11 Months | Current |
| Satyarth Chaudhary | Director | 31 May 2018 | 8 Years 4 Months | Current |
Auditor
Rcsat Pharmaceuticals Private Limited is audited by RITANSHU GUPTA & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RITANSHU GUPTA & CO | FY 2023 | 020354C |
Shareholding
The shareholding of Rcsat Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Rcsat Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rcsat Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rcsat Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rcsat Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICR0084N1ZW | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rcsat Pharmaceuticals Private Limited, buy the company report.
Recent activity
Rcsat Pharmaceuticals Private Limited has 4 board changes on record since 2016: 4 appointments. The latest: Aparna Rajnath Singh was appointed as Director on 31 May 2018.
Frequently asked questions
Rcsat Pharmaceuticals is an active private limited company based in Meerut, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 November 2016 (10+ years old) and is registered under CIN U74999UP2016PTC087624.
Rcsat Pharmaceuticals has 4 current directors:
- Chandresh - Director
- Aparna Rajnath Singh - Director
- Ram Chander - Director
- Satyarth Chaudhary - Director
The latest financial statements of Rcsat Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Rcsat Pharmaceuticals is 09AAICR0084N1ZW, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Rcsat Pharmaceuticals is U74999UP2016PTC087624. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rcsat Pharmaceuticals was incorporated on 09 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kanpur.
Aparna Rajnath Singh was appointed as Director on 31 May 2018. Satyarth Chaudhary was appointed as Director on 31 May 2018. Chandresh was appointed as Director on 09 Nov 2016. Rcsat Pharmaceuticals has 4 board changes on record in total.
The registered office of Rcsat Pharmaceuticals is at H No. 148 Akshardham Colony Roorkee Road, Meerut, Uttar Pradesh, India – 250110.
Rcsat Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Rcsat Pharmaceuticals is compliant as of 19 July 2026. The company is actively filing with the Registrar of Companies.